|
TRMT11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.081700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.501900E-02 |
| Normal-vs-Stage2 |
5.396000E-01 |
| Normal-vs-Stage3 |
2.191600E-01 |
| Normal-vs-Stage4 |
1.907950E-02 |
| Stage1-vs-Stage2 |
1.189690E-02 |
| Stage1-vs-Stage3 |
3.860000E-01 |
| Stage1-vs-Stage4 |
5.408800E-01 |
| Stage2-vs-Stage3 |
1.016020E-01 |
| Stage2-vs-Stage4 |
1.293870E-02 |
| Stage3-vs-Stage4 |
2.277400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.979700E-02 |
| Normal-vs-AfricanAmerican |
1.673710E-02 |
| Normal-vs-Asian |
6.735200E-03 |
| Caucasian-vs-AfricanAmerican |
1.492190E-01 |
| Caucasian-vs-Asian |
9.341500E-02 |
| AfricanAmerican-vs-Asian |
8.623000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.917400E-01 |
| Normal-vs-Female |
2.665700E-02 |
| Male-vs-Female |
1.451420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.272200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.537420E-01 |
| Normal-vs-Age(61-80Yrs) |
5.238000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.171800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.122200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.415500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.614400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.046600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.386400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.778400E-01 |
| Classical-VS-Follicular |
4.40339999999706E-05 |
| Classical-VS-Other |
9.022600E-01 |
| Classical-VS-Normal |
7.542100E-03 |
| Tall-VS-Follicular |
2.979700E-02 |
| Tall-VS-Other |
9.161000E-01 |
| Tall-VS-Normal |
5.967800E-02 |
| Follicular-VS-Other |
2.701600E-01 |
| Follicular-VS-Normal |
5.106200E-01 |
| Other-VS-Normal |
2.872600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.063000E-01 |
| Normal-vs-N1 |
1.845790E-02 |
| N0-vs-N1 |
1.432120E-02 |
|
|
